Skip to main content Skip to main navigation menu Skip to site footer
International Journal of Nutrology
Articles
DOI: 10.1055/s-0040-1721663
Submitted: 03-07-2022
Published: 03-07-2022

Critério da Associação Brasileira de Nutrologia para diagnóstico e tratamento da síndrome metabólica em crianças e adolescentes

Departamento de Medicina, Universidade Federal de São Carlos, São Carlos, SP, Brasil
Departamento de Endocrinologia Pediátrica, Sociedade de Pediatria de São Paulo, São Paulo, SP, Brasil
Departamento de Nutrição, Sociedade de Pediatria de São Paulo, São Paulo, SP, Brasil
Departamento de Pediatria,Centro Universitário UniFacid Wyden, Teresina, PI, Brasil
Departamento de Nutrologia, Faculdade de Medicina, Fundação Padre Albino (FAMECA), Catanduva, São Paulo, Brasil
obesity metabolic syndrome children adolescents consensus

Abstract

Introduction: Metabolic Syndrome is a set of biochemical, physiological, clinical and metabolic factors that start with peripheral insulin resistance and that, when concomitantly present, increase the risk of developing atherosclerosis, cardiovascular events, type 2 diabetes mellitus and mortality from any cause. In children, there is no consensus on diagnostic criteria and treatment, so the importance of their establishment and standardization. Objective: To publish a consensus of the Brazilian Association of Nutrology for the diagnosis and treatment of Metabolic Syndrome in children and adolescents. Methods: Literature review and discussion among authors. Results: For diagnosis, it is recommended to use the following parameters: excess body adiposity, dyslipidemia, alteration of glycemic-insulinemic profile and elevation of blood pressure. Adolescents and children aged seven years or older will be diagnosed with metabolic syndrome if present altered values in at least 3 of the 4 criteria. Lifestyle modifications, improvement in the quantity and quality of food and increased physical activity are used as initial therapy and the use of metformin is indicated for the control of insulin resistance when those strategies will be not sufficient. Liraglutide can be used in people over 12 years of age to promote weight loss and bariatric surgery is reserved for special cases of severe obesity. Conclusion: Early recognition and treatment of Metabolic Syndrome among children and adolescents provide prevention of cardiovascular adverse events and diabetes in patients and improves their quality of life and the present consensus seeks to standardize these conducts.

Metrics

Metrics Loading ...

References

  1. Reaven GM. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 1988; 37 (12) 1595-1607 DOI: 10.2337/diab.37.12.1595.
  2. Félix NDDC, Nóbrega MMLd. Síndrome metabólica: análise conceitual no contexto da enfermagem. Rev Lat Am Enfermagem 2019; 27 DOI: 10.1590/1518-8345.3008.3154.
  3. SBD. Diretrizes da Sociedade Brasileira de Diabetes-2019-2020. SBD São Paulo; 2019
  4. Al-Hamad D, Raman V. Metabolic syndrome in children and adolescents. Transl Pediatr 2017; 6 (04) 397-407 DOI: 10.21037/tp.2017.10.02.
  5. Ramires EKNM, Menezes RCE, Longo-Silva G, Santos TGD, Marinho PM, Silveira JACD. Prevalence and Factors Associated with Metabolic Syndrome among Brazilian Adult Population: National Health Survey - 2013. Arq Bras Cardiol 2018; 110 (05) 455-466 http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0066-782X2018000500455&nrm=iso
  6. Nogueira-de-Almeida CA, Mello ED. Síndrome Metabólica. In: Nogueira-de-Almeida CA, Mello ED. editors. Nutrologia Pediátrica - Prática Baseada em Evidências. 1. 1 ed.. São Paulo: Manole; 2016: 157-168
  7. Fontelles CC, Guido LN, Andrade FO, Ong TP. Nutrição e Epigenética. In: Dal Bosco SM, Genro JP. editors. Nutrigenética e implicações na saúde humana. São Paulo, SP: Atheneu; 2014: 179-200
  8. Lopes VP, Maia JAR. Períodos críticos ou sensíveis: revisitar um tema polêmico à luz da investigação empírica. Revista Paulista de Educação Física. 2000; 14: 128-140 DOI: 10.11606/issn.2594-5904.rpef.2000.138608.
  9. Huang C, Cerrell SG, Kissane B, Bates N, Alipui N, Isaacs S. Why 1,000 days: thousanddays.org. 2020 [Available from: https://thousanddays.org/why-1000-days/
  10. Nogueira De Almeida CA. We Need To Look At the Comorbidities of Obesity during Childhood and Adolescence. Biomedical Journal of Scientific & Techinical Research. 2017; 1: 2 DOI: 10.26717/BJSTR.2017.01.000586.
  11. Hong Y, Pedersen NL, Brismar K, de Faire U. Genetic and environmental architecture of the features of the insulin-resistance syndrome. Am J Hum Genet 1997; 60 (01) 143-152
  12. Thota P, Perez-Lopez FR, Benites-Zapata VA, Pasupuleti V, Hernandez AV. Obesity-related insulin resistance in adolescents: a systematic review and meta-analysis of observational studies. Gynecol Endocrinol 2017; 33 (03) 179-184 DOI: 10.1080/09513590.2016.1273897.
  13. Greenfield MS, Doberne L, Kraemer F, Tobey T, Reaven G. Assessment of insulin resistance with the insulin suppression test and the euglycemic clamp. Diabetes 1981; 30 (05) 387-392 DOI: 10.2337/diab.30.5.387.
  14. Xavier HT, Izar M, Faria Neto J. et al. V Diretriz brasileira de dislipidemias e prevenção da aterosclerose. Arq Bras Cardiol 2013; 101 (04) (Suppl. 01) 1-20
  15. Cook S, Weitzman M, Auinger P, Nguyen M, Dietz WH. Prevalence of a metabolic syndrome phenotype in adolescents: findings from the third National Health and Nutrition Examination Survey, 1988-1994. Arch Pediatr Adolesc Med 2003; 157 (08) 821-827 DOI: 10.1001/archpedi.157.8.821.
  16. Styne DM, Arslanian SA, Connor EL. et al. Pediatric Obesity-Assessment, Treatment, and Prevention: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 2017; 102 (03) 709-757 DOI: 10.1210/jc.2016-2573.
  17. Rodríguez-Morán M, Salazar-Vázquez B, Violante R, Guerrero-Romero F. Metabolic syndrome among children and adolescents aged 10-18 years. Diabetes Care 2004; 27 (10) 2516-2517 DOI: 10.2337/diacare.27.10.2516.
  18. Strufaldi MWL, Silva EM, Puccini RF. Metabolic syndrome among prepubertal Brazilian schoolchildren. Diab Vasc Dis Res 2008; 5 (04) 291-297 DOI: 10.3132/dvdr.2008.042.
  19. Pinho AP, Brunetti IL, Pepato MT, Almeida C. Metabolic syndrome in overweight/obese female adolescents. Rev Paul Pediatr 2012; 30: 51-56
  20. Burrows R, Correa-Burrows P, Reyes M, Blanco E, Albala C, Gahagan S. Healthy Chilean Adolescents with HOMA-IR ≥ 2.6 Have Increased Cardiometabolic Risk: Association with Genetic, Biological, and Environmental Factors. J Diabetes Res 2015; 2015: 783296 DOI: 10.1155/2015/783296.
  21. Reilly JJ, Armstrong J, Dorosty AR. et al; Avon Longitudinal Study of Parents and Children Study Team. Early life risk factors for obesity in childhood: cohort study. BMJ 2005; 330 (7504): 1357 DOI: 10.1136/bmj.38470.670903.E0.
  22. Ten S, Maclaren N. Insulin resistance syndrome in children. J Clin Endocrinol Metab 2004; 89 (06) 2526-2539
  23. Brasil AR. Crianças e adolescentes com sobrepeso ou obesidade: avaliação da reação infalmatória através da dosagem de proteína C reativa ultra sensível e prevalência de síndrome metabólica. Belo Horizonte: UFMG; 2006
  24. Cook S, Weitzman M, Auinger P, Nguyen M, Dietz WH. Prevalence of a metabolic syndrome phenotype in adolescents: findings from the third National Health and Nutrition Examination Survey, 1988-1994. Arch Pediatr Adolesc Med 2003; 157 (08) 821-827
  25. Moran A, Jacobs Jr DR, Steinberger J. et al. Insulin resistance during puberty: results from clamp studies in 357 children. Diabetes 1999; 48 (10) 2039-2044
  26. Sinaiko AR, Steinberger J, Moran A. et al. Relation of body mass index and insulin resistance to cardiovascular risk factors, inflammatory factors, and oxidative stress during adolescence. Circulation 2005; 111 (15) 1985-1991
  27. Cuartero BG, Lacalle CG, Lobo CJ. et al. ÷ndice HOMA y QUICKI, insulina y pÇptido C en ni§os sanos. Puntos de corte de riesgo cardiovascular. An Pediatr (Barc) 2007; 66: 481-490
  28. Lee SH, Ahn MB, Choi YJ. et al. A comparison of different criteria for the definition of insulin resistance and its relationship to metabolic risk in children and adolescents. Ann Pediatr Endocrinol Metab 2020; x: x
  29. Almeida CA, Pinho AP, Ricco RG, Pepato MT, Brunetti IL. Determination of glycemia and insulinemia and the homeostasis model assessment (HOMA) in schoolchildren and adolescents with normal body mass index. J Pediatr (Rio J) 2008; 84 (02) 136-140 DOI: 10.2223/JPED.1767.
  30. Mieldazis SF, Azzalis LA, Junqueira VB, Souza FI, Sarni RO, Fonseca FL. Hyperinsulinism assessment in a sample of prepubescent children. J Pediatr (Rio J) 2010; 86 (03) 245-249 DOI: 10.2223/JPED.1993.
  31. Weiss R, Dziura J, Burgert TS. et al. Obesity and the metabolic syndrome in children and adolescents. N Engl J Med 2004; 350 (23) 2362-2374 DOI: 10.1056/NEJMoa031049.
  32. DeBoer MD. Assessing and Managing the Metabolic Syndrome in Children and Adolescents. Nutrients 2019; 11 (08) E1788 DOI: 10.3390/nu11081788.
  33. Christian Flemming GM, Bussler S, Körner A, Kiess W. Definition and early diagnosis of metabolic syndrome in children. J Pediatr Endocrinol Metab 2020; 33 (07) 821-833 DOI: 10.1515/jpem-2019-0552.
  34. Ten S, Maclaren N. Insulin resistance syndrome in children. J Clin Endocrinol Metab 2004; 89 (06) 2526-2539 DOI: 10.1210/jc.2004-0276.
  35. Damiani D, Kuba VM, Cominato L, Damiani D, Dichtchekenian V, Menezes Filho HC. Síndrome metabólica em crianças e adolescentes: dúvidas na terminologia, mas não nos riscos cardiometabólicos. Arq Bras Endocrinol Metabol 2011; 55 (08) 576-582 http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0004-27302011000800011&nrm=iso
  36. Weihe P, Weihrauch-Blüher S. Metabolic Syndrome in Children and Adolescents: Diagnostic Criteria, Therapeutic Options and Perspectives. Curr Obes Rep 2019; 8 (04) 472-479 DOI: 10.1007/s13679-019-00357-x.
  37. de Ferranti SD, Gauvreau K, Ludwig DS, Neufeld EJ, Newburger JW, Rifai N. Prevalence of the metabolic syndrome in American adolescents: findings from the Third National Health and Nutrition Examination Survey. Circulation 2004; 110 (16) 2494-2497 DOI: 10.1161/01.Cir.0000145117.40114.C7.
  38. Zimmet P, Alberti KGMM, Kaufman F. et al; IDF Consensus Group. The metabolic syndrome in children and adolescents - an IDF consensus report. Pediatr Diabetes 2007; 8 (05) 299-306 DOI: 10.1111/j.1399-5448.2007.00271.x.
  39. Ahrens W, Moreno LA, Mårild S. et al; IDEFICS consortium. Metabolic syndrome in young children: definitions and results of the IDEFICS study. Int J Obes 2014; 38 (Suppl. 02) S4-S14 DOI: 10.1038/ijo.2014.130.
  40. Engelmann G, Lenhartz H, Grulich-Henn J. Obesity and the metabolic syndrome in children and adolescents. N Engl J Med 2004; 351 (11) 1146-1148 , author reply 1146–1148 DOI: 10.1056/NEJM200409093511119.
  41. Mokha JS, Srinivasan SR, Dasmahapatra P. et al. Utility of waist-to-height ratio in assessing the status of central obesity and related cardiometabolic risk profile among normal weight and overweight/obese children: the Bogalusa Heart Study. BMC Pediatr 2010; 10: 73 DOI: 10.1186/1471-2431-10-73.
  42. Olza J, Gil-Campos M, Leis R. et al. Presence of the metabolic syndrome in obese children at prepubertal age. Ann Nutr Metab 2011; 58 (04) 343-350 DOI: 10.1159/000331996.
  43. Nogueira-de-Almeida CA, de Mello ED. Different Criteria for the Definition of Insulin Resistance and Its Relation with Dyslipidemia in Overweight and Obese Children and Adolescents. Pediatr Gastroenterol Hepatol Nutr 2018; 21 (01) 59-67 DOI: 10.5223/pghn.2018.21.1.59.
  44. Flynn JT, Kaelber DC, Baker-Smith CM. et al; SUBCOMMITTEE ON SCREENING AND MANAGEMENT OF HIGH BLOOD PRESSURE IN CHILDREN. Clinical Practice Guideline for Screening and Management of High Blood Pressure in Children and Adolescents. Pediatrics 2017; 140 (03) e20171904 DOI: 10.1542/peds.2017-1904.
  45. Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents, National Heart, Lung, and Blood Institute. Expert panel on integrated guidelines for cardiovascular health and risk reduction in children and adolescents: summary report. Pediatrics 2011; 128 (Suppl. 05) S213-S256 DOI: 10.1542/peds.2009-2107C.
  46. Knowler WC, Barrett-Connor E, Fowler SE. et al; Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002; 346 (06) 393-403 DOI: 10.1056/NEJMoa012512.
  47. Whitlock EP, O'Conner EA, Williams SB, Beil TL, Lutz KW. Effectiveness of Primary Care Interventions for Weight Management in Children and Adolescents: An Updated, Targeted Systematic Review for the USPSTF. U.S. Preventive Services Task Force Evidence Syntheses, formerly Systematic Evidence Reviews 2010; 76: x
  48. Kelly AS, Auerbach P, Barrientos-Perez M. et al; NN8022-4180 Trial Investigators. A Randomized, Controlled Trial of Liraglutide for Adolescents with Obesity. N Engl J Med 2020; 382 (22) 2117-2128 DOI: 10.1056/NEJMoa1916038.
  49. ANVISA. Saxenda (liraglutida): nova indicação Brasília: ANVISA. 2020 [Available from: https://www.gov.br/anvisa/pt-br/assuntos/medicamentos/novos-medicamentos-e-indicacoes/saxenda-liraglutida-nova-indicacao
  50. Inge TH, Courcoulas AP, Jenkins TM. et al; Teen-LABS Consortium. Weight Loss and Health Status 3 Years after Bariatric Surgery in Adolescents. N Engl J Med 2016; 374 (02) 113-123 DOI: 10.1056/NEJMoa1506699.
  51. McGuire SUS. Department of Agriculture and U.S. Department of Health and Human Services, Dietary Guidelines for Americans, 2010. 7th Edition,. Washington, DC: U.S. Government Printing Office; , January 2011. Advances in Nutrition. 2011. 2. 293-294 DOI: 10.3945/an.111.000430
  52. Magge SN, Goodman E, Armstrong SC. COMMITTEE ON NUTRITION, SECTION ON ENDOCRINOLOGY, SECTION ON OBESITY. The Metabolic Syndrome in Children and Adolescents: Shifting the Focus to Cardiometabolic Risk Factor Clustering. Pediatrics 2017; 140 (02) e20171603 DOI: 10.1542/peds.2017-1603.
  53. Fornari E, Maffeis C. Treatment of Metabolic Syndrome in Children. Front Endocrinol (Lausanne) 2019; 10: 702 DOI: 10.3389/fendo.2019.00702.
  54. Jääskeläinen A, Schwab U, Kolehmainen M, Pirkola J, Järvelin MR, Laitinen J. Associations of meal frequency and breakfast with obesity and metabolic syndrome traits in adolescents of Northern Finland Birth Cohort 1986. Nutr Metab Cardiovasc Dis 2013; 23 (10) 1002-1009 DOI: 10.1016/j.numecd.2012.07.006.
  55. Jung CH, Lee JS, Ahn HJ. et al. Association of meal frequency with metabolic syndrome in Korean adults: from the Korea National Health and Nutrition Examination Survey (KNHANES). Diabetol Metab Syndr 2017; 9: 77 DOI: 10.1186/s13098-017-0277-2.
  56. Dehghan M, Akhtar-Danesh N, Merchant AT. Childhood obesity, prevalence and prevention. Nutr J 2005; 4: 24 DOI: 10.1186/1475-2891-4-24.
  57. Pedroni JL, Rech RR, Halpern R. et al. Prevalência de obesidade abdominal e excesso de gordura em escolares de uma cidade serrana no sul do Brasil. Cien Saude Colet 2013; 18 (05) 1417-1425
  58. Silva FM, Steemburgo T, Azevedo MJ, Mello VD. Papel do índice glicêmico e da carga glicêmica na prevenção e no controle metabólico de pacientes com diabetes melito tipo 2. Arq Bras Endocrinol Metabol 2009; 53 (05) 560-571 http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0004-27302009000500009&nrm=iso
  59. Carvalho GQ. Alfenas RdCG. Índice glicêmico: uma abordagem crítica acerca de sua utilização na prevenção e no tratamento de fatores de risco cardiovasculares. Rev Nutr 2008; 21: 577-587 http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1415-52732008000500010&nrm=iso
  60. Scott SN, Anderson L, Morton JP, Wagenmakers AJM, Riddell MC. Carbohydrate Restriction in Type 1 Diabetes: A Realistic Therapy for Improved Glycaemic Control and Athletic Performance?. Nutrients 2019; 11 (05) E1022 DOI: 10.3390/nu11051022.
  61. Sadeghi A, Mousavi SM, Mokhtari T, Parohan M, Milajerdi A. Metformin Therapy Reduces Obesity Indices in Children and Adolescents: A Systematic Review and Meta-Analysis of Randomized Clinical Trials. Child Obes 2020; 16 (03) 174-191 DOI: 10.1089/chi.2019.0040.
  62. Group DPPR. Diabetes Prevention Program Research Group. Long-term Effects of Metformin on Diabetes Prevention: Identification of Subgroups That Benefited Most in the Diabetes Prevention Program and Diabetes Prevention Program Outcomes Study. Diabetes Care 2019; 42 (04) 601-608 DOI: 10.2337/dc18-1970dc181970.10.2337/dc18-1970.
  63. Khokhar A, Umpaichitra V, Chin VL, Perez-Colon S. Metformin Use in Children and Adolescents with Prediabetes. Pediatr Clin North Am 2017; 64 (06) 1341-1353 DOI: 10.1016/j.pcl.2017.08.010.
  64. Quinn SM, Baur LA, Garnett SP, Cowell CT. Treatment of clinical insulin resistance in children: a systematic review. Obes Rev 2010; 11 (10) 722-730 DOI: 10.1111/j.1467-789X.2009.00697.x.
  65. Park MH, Kinra S, Ward KJ, White B, Viner RM. Metformin for obesity in children and adolescents: a systematic review. Diabetes Care 2009; 32 (09) 1743-1745 DOI: 10.2337/dc09-0258.
  66. Srinivasan S, Ambler GR, Baur LA. et al. Randomized, controlled trial of metformin for obesity and insulin resistance in children and adolescents: improvement in body composition and fasting insulin. J Clin Endocrinol Metab 2006; 91 (06) 2074-2080 DOI: 10.1210/jc.2006-0241.
  67. Nogueira-de-Almeida CA, de Mello ED, de Mello PP, de Mello PD, Zorzo RA, Ribas Filho D. Consenso da Associação Brasileira de Nutrologia sobre manejo da dislipidemia secundária à obesidade infanto-juvenil. Int J Neurol 2017; 10: 161-178
  68. Falkner B, Daniels SR. Summary of the Fourth Report on the Diagnosis, Evaluation, and Treatment of High Blood Pressure in Children and Adolescents. Hypertension 2004; 44 (04) 387-388 DOI: 10.1161/01.HYP.0000143545.54637.af.
  69. Malachias MV. 7th Brazilian Guideline of Arterial Hypertension: Presentation. Arq Bras Cardiol 2016; 107 (03) (Suppl. 03) 0 http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0066-782X2016004800001&nrm=iso
  70. Brady TM, Redwine KM, Flynn JT. American Society of Pediatric Nephrology. Screening blood pressure measurement in children: are we saving lives?. Pediatr Nephrol 2014; 29 (06) 947-950 DOI: 10.1007/s00467-013-2715-1.
  71. Costa KCM, Lima JC. Almeida CANd, Ciampo LAD, Souza CSBd. Variation of the brachial artery diameter in obese children: present and future. Rev Paul Pediatr 2012; 30: 431-437
  72. Caixe SH, Garcia Saab Benedeti AC, Garcia J, Martins WDP, Mauad Filho F, Del Ciampo LA. et al. Evaluation of Echocardiography as a Marker of Cardiovascular Risk in Obese Children and Adolescents. Int J Clin Pediatr 2014; 3: 7 DOI: 10.14740/ijcp164w.
  73. Nogueira-de-Almeida CA, Benedeti ACGS, Garcia J, Caixe SH. Correlation Between Ultrasonographic Measures of the Abdominal Adiposity and Indicators of Obesity in Normal and Overweight/Obesity Children. FASEB J 2016; 30: 1165
  74. Nogueira-de-Almeida CA, Caixe SH, Benedeti ACGS, Garcia J. Echocardiography Evaluation as a Marker of Cardiovascular Risk on Obese Children and Adolescents. FASEB J 2016; 30: 126
  75. Nogueira-de-Almeida CA, Garcia J, Caixe SH, Benedeti ACGS. Ultrasonographic Assessment of the Common Carotid Intima-Media Complex in Normal Weight Children and in Overweight/Obese Children. FASEB J 2016; 30: 1165
  76. Costa KCM, Ciampo LAD, Silva PS, Lima JC, Martins WP, Nogueira de Almeida CA. Ultrasonographic markers of cardiovascular disease risk in obese children. Rev Paul Pediatr 2018; 36 (02) 171-175 DOI: 10.1590/1984-0462/;2018;36;2;000160.10.1590/1984-0462/;2018;36;2;00016.
  77. Garcia J, Benedeti ACGS, Caixe SH, Mauad Filho F, Nogueira-de-Almeida CA. Avaliação ultrassonográfica do complexo médio-intimal das carótidas comuns em crianças eutróficas e portadoras de sobrepeso/obesidade. J Vasc Bras 2019; 18: ••• http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1677-54492019000100314&nrm=iso
  78. SBP. Hipertensão arterial na infância e adolescência. DC Nefrologia;. 2019 https://www.sbp.com.br/fileadmin/user_upload/21635c-MO_-_Hipertensao_Arterial_Infanc_e_Adolesc.pdf
  79. Lurbe E, Agabiti-Rosei E, Cruickshank JK. et al. 2016 European Society of Hypertension guidelines for the management of high blood pressure in children and adolescents. J Hypertens 2016; 34 (10) 1887-1920 https://journals.lww.com/jhypertension/Fulltext/2016/10000/2016_European_Society_of_Hypertension_guidelines.2.aspx
  80. Paula Bricarello L, Poltronieri F, Fernandes R, Retondario A, de Moraes Trindade EBS, de Vasconcelos FAG. Effects of the Dietary Approach to Stop Hypertension (DASH) diet on blood pressure, overweight and obesity in adolescents: A systematic review. Clin Nutr ESPEN 2018; 28: 1-11 DOI: 10.1016/j.clnesp.2018.09.003.
  81. Asghari G, Yuzbashian E, Mirmiran P, Hooshmand F, Najafi R, Azizi F. Dietary Approaches to Stop Hypertension (DASH) Dietary Pattern Is Associated with Reduced Incidence of Metabolic Syndrome in Children and Adolescents. J Pediatr 2016; 174: 178-184.e1 DOI: 10.1016/j.jpeds.2016.03.077.
  82. Burrello J, Erhardt EM, Saint-Hilary G. et al. Pharmacological Treatment of Arterial Hypertension in Children and Adolescents: A Network Meta-Analysis. Hypertension 2018; 72 (02) 306-313 DOI: 10.1161/HYPERTENSIONAHA.118.10862.

How to Cite

Nogueira-de-Almeida, C. A., Hirose, T. S., Zorzo, R. A., Vilanova, K. C. M., & Ribas Filho, D. (2022). Critério da Associação Brasileira de Nutrologia para diagnóstico e tratamento da síndrome metabólica em crianças e adolescentes. International Journal of Nutrology, 13(3), 54–68. https://doi.org/10.1055/s-0040-1721663